Condensed Consolidated Statement of Changes in Shareholders' Deficit (Unaudited) - 3 months ended Mar. 31, 2018 - USD ($)	Total	Common Stock	Common Stock Issuable	Additional Paid-in Capital	Accumulated Deficit
Balance at Dec. 31, 2017	$ (2,051,413)	$ 7,230	$ 8,276	$ 2,638,311	$ (4,705,230)
Balance, Shares at Dec. 31, 2017		72,302,937
Sale of common stock	133,611	$ 63	236	133,312
Sale of common stock, Shares		631,204
Fair value of warrants allocated to proceeds of common stock	117,956			117,956
Fair value of warrants issued to extend related party notes payable	337,467			337,467
Fair value of warrants issued to extend convertible notes payable	10,199			10,199
Consultant fees payable with common shares and warrants	5,287		5,287
Shares and options issued pursuant to employee equity incentive plan	5,577	$ 8	(8)	5,577
Shares and options issued pursuant to employee equity incentive plan, Shares		75,000
Net loss	(1,281,108)				(1,281,108)
Balance at Mar. 31, 2018	$ (2,722,424)	$ 7,301	$ 13,791	$ 3,242,822	$ (5,986,338)
Balance, Shares at Mar. 31, 2018		73,009,141